CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corporation

The latest update is out from CVS Group plc ( ($GB:CVSG) ). CVS Group plc has confirmed that its total issued share capital stands at 70,156,093 or...

CVS Group Confirms Total Voting Rights at Just Over 70 Million Shares

CVS Group plc ( ($GB:CVSG) ) just unveiled an update. CVS Group has welcomed the UK Government’s decision to launch an eight-week consultation on r...

CVS Group Backs DEFRA Consultation on Overhaul of Veterinary Surgeons Act

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CVS Health (CVS – Research Report), Revolution Medic...

Analysts’ Top Healthcare Picks: CVS Health (CVS), Revolution Medicines (RVMD)

Health insurer stocks are under pressure today after investors reacted negatively to new Medicare pricing plans. The weakness follows a proposal fr...

UNH, CVS, HUM: Why Health Insurer Stocks Are Under Pressure Today

In a report released today, Lance Wilkes from Bernstein maintained a Hold rating on CVS Health, with a price target of $91.00. According to TipRank...

Bernstein Keeps Their Hold Rating on CVS Health (CVS)

RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health yesterday and set a price target of $93.00. According to TipRanks, Hendrix is...

RBC Capital Keeps Their Buy Rating on CVS Health (CVS)

U.S. stocks finished the week essentially flat as a semiconductor-led bid was offset by softer bank performance and a steady drumbeat of policy hea...

The Week That Was, The Week Ahead: Macro and Markets, Jan. 18

UnitedHealth ($UNH) stock has declined more than 34% over the past year due to several headwinds, including concerns about high medical costs in th...

Is UnitedHealth Stock (UNH) a Buy Ahead of Q4 Earnings?

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health today and set a price target of $91.00. According to TipRanks, Wilkes is an a...

CVS Health (CVS) Receives a Hold from Bernstein

CVS Group plc ( ($GB:CVSG) ) has shared an update. CVS Group plc reported that non-executive director Richard Gray has increased his personal stake...

CVS Group Non-Executive Director Richard Gray Increases Shareholding

Lilly’s new weight-loss pill is expected this summer. 


	A	B	C	D
1	Symbol	Price	Change	Volume
2	CVS	$75.42	+1.21%	10.71M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CVS	$75.42	+1.2%	10.71M
3
4
5
6

CVS

CVS

No Data Available

Get CVS Health Corporation Data in Excel

Get CVS Health Corporation Data in Excel